Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
4 Jul - 4 Aug 2006
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP-guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2006
Report date:
2006

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
yes
Remarks:
relative humidity was higher than 70% on several days of the study, this did not effect the study outcome.
GLP compliance:
yes (incl. QA statement)
Remarks:
Niedersächsisches Landesamt für Ökologie, Hildesheim, Germany
Type of study:
guinea pig maximisation test

Test material

Constituent 1
Chemical structure
Reference substance name:
Sorbitan, octanoate (2:3)
EC Number:
295-118-4
EC Name:
Sorbitan, octanoate (2:3)
Cas Number:
91844-53-0
Molecular formula:
Not available for UVCB
IUPAC Name:
Sorbitan, octanoate (2:3)
Details on test material:
- Name of test material (as cited in study report): Only trade name given
- Substance type: organic
- Physical state: amber liquid
- Analytical purity: no data
- Lot/batch No.: ES665M0001
- Expiration date of the lot/batch: June 2007
- Storage condition of test material: room temperature (20 ± 2 °C)

In vivo test system

Test animals

Species:
guinea pig
Strain:
other: HsdPoc.DH
Sex:
male/female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Harlan Winkelmann GmbH, Borchen, Germany
- Weight at study initiation: males: 396 - 444 g; females: 376 - 408 g
- Housing: group-housed for up to a maximum of 5 animals per cage in a battery of cages, equipped with a paper disposal system
- Diet: "Teklad Global Guinea Pig Diet" (pelleted diet) produced by Harlan Teklad, Blackthorn Bicester, Oxon, England (Batch No. N113), ad libitum.
- Water: Tap water as for human consumption was continuously available, ad libitum.
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 °C - 23 °C
- Humidity (%): 50% - 83%
- Air changes (per hr): 16 per h
- Photoperiod (hrs dark / hrs light): 12/12

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal and epicutaneous
Vehicle:
peanut oil
Concentration / amount:
Induction: intradermal 5%, epidermal 100%
Challenge: 100%
Challengeopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
peanut oil
Concentration / amount:
Induction: intradermal 5%, epidermal 100%
Challenge: 100%
No. of animals per dose:
5 (controls), 10 (in test group)
Details on study design:
RANGE FINDING TESTS:
For the intradermal injection, the test article was diluted with aqua ad injectabilia and Freund's complete adjuvant (FCA; batch No. 054K8931, SIGMA, Steinheim) to a final concentration of 5.0%. Two animals were treated, skin reactions were recorded 48 h and 72 h after treatment. For the dermal application, the liquid article was used undiluted. A closed patch exposure was effected by means of an occlusive bandage using cellulose swabs (Pur-Zellin®, Hartmann AG, Heidenheim/Brenz), Leukosilk® (Beiersdorf AG, Hamburg) and non-irritating tape Elastoplast® (Beiersdorf AG, Hamburg), which enveloped the whole animal's trunk. Two animals were employed and skin reactions were recorded 48 and 72 h post application.

According to the results obtained in the preliminary test, the concentrations of the test article used in the main test were 100% (undiluted) for dermal application and 5% for intradermal injection.

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and epicutaneous, respectively)
- Exposure period: single injection (intradermal) and 48 h (epicutaneous)
- Test groups:
Intradermal (3 pairs of injections):
Injection 1: a 1:1 mixture (v/v) FCA/water
Injection 2: test substance in vehicle (peanut oil)
Injection 3: test substance in a 1:1 mixture (v/v) FCA/peanut oil

Epicutaneous: seven days after intradermal induction the previous injection sites were covered occlusively for 48 h with a patch carrying the test article (100%)

- Control group:
Intradermal (3 pairs of injections):
Injection 1: a 1:1 mixture (v/v) FCA/water
Injection 2: vehicle (peanut oil)
Injection 3: vehicle (peanut oil) in FCA

Epicutaneous: seven days after intradermal induction the previous injection sites were covered occlusively for 48 h with a patch carrying the vehicle

- Site: either side of spine (intradermal + epicutaneous)
- Frequency of applications and duration:
intradermal induction: single application at test start
epidermal induction: seven days after intradermal induction, for 48 hours
- Concentrations: three pairs of intradermal injections 5%, epidermal 100%

B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 14 days after end of epidermal induction
- Exposure period: 24 h
- Test groups: test substance and vehicle only
- Control group: test substance and vehicle only
- Site: right flank (vehicle) and left flank (test substance)
- Concentrations: 100%
- Evaluation (hr after challenge): 24 and 48 h
Challenge controls:
The control group is actually a challenge control
Positive control substance(s):
yes
Remarks:
4-aminobenzoic acid ethyl ester (benzocaine, CAS: 94-09-7, Batch 044K0697) in vaseline

Results and discussion

Positive control results:
The positive control substance (50% 4-aminobenzoic acid in vaseline) induced positive reactions in 5/10 animals (50%), thus meeting
the reliability criteria for the GPMT test (≥ 30% positive response).

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
100 %
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 100 %. No with. + reactions: 0.0. Total no. in groups: 10.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
100 %
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 100 %. No with. + reactions: 0.0. Total no. in groups: 10.0.
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
100 %
No. with + reactions:
0
Total no. in group:
5
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 100 %. No with. + reactions: 0.0. Total no. in groups: 5.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
100 %
No. with + reactions:
0
Total no. in group:
5
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 100 %. No with. + reactions: 0.0. Total no. in groups: 5.0.
Reading:
1st reading
Hours after challenge:
24
Group:
positive control
Dose level:
50 %
No. with + reactions:
5
Total no. in group:
10
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: positive control. Dose level: 50 %. No with. + reactions: 5.0. Total no. in groups: 10.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
positive control
Dose level:
50 %
No. with + reactions:
5
Total no. in group:
10
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: positive control. Dose level: 50 %. No with. + reactions: 5.0. Total no. in groups: 10.0.

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
CLP: not classified
DSD: not classified